Skip to main content

Immunology of Guillain-Barré Syndrome

  • Chapter
Guillain-Barré Syndrome

Part of the book series: Clinical Medicine and the Nervous System ((CLIN.MED.NERV.))

  • 205 Accesses

Abstract

The combination of increased CSF protein concentration and normal cell count was used by Guillain et al. (1916) as a distinguishing feature of the two cases in their original description. This combination remains the most helpful laboratory guide to the diagnosis of GBS but is not an invariable feature. In large series this “albuminocytological dissociation” is reported in about 80%–90% of patients. For instance, in a prospective study of 100 cases in south east England CSF total protein concentrations were abnormal in 80%; the mean concentration was 1.2 g/1 and range 0.1–6.0 g/1. The CSF white cell count was normal in 90%: those patients having a pleocytosis had very few cells, median 8 per µl and range 6–103 per µl (Winer et al. 1988d). Single observations on individual patients suggest that the CSF protein concentration commonly remains normal during the first ten days of the illness, increases as the disease progresses, continues to rise during the plateau and early recovery phases and eventually returns to normal (Wiederholt et al. 1964). This time course was confirmed by serial lumbar punctures in a typical case (Link 1975). No clinical differences have been discovered between those patients with persistently normal CSF protein concentrations and those exhibiting the classical albuminocytological dissociation, although differences, especially in outcome, have been sought in almost every published series.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aarli JA, Aparicio SR, Lumsden CE, Tonder O (1975) Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology 28: 171–185

    PubMed  CAS  Google Scholar 

  • Abbas DH, Schlagenhauff RE, Strong HE (1977) Polyradiculoneuropathy in Addison’s disease. Neurology 27: 494–495

    PubMed  CAS  Google Scholar 

  • Abramsky O, Webb C, Teitelbaum D, Arnon R (1975) Cell mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Neurology 25: 1154–1159

    PubMed  CAS  Google Scholar 

  • Abramsky O, Korn-Lubetzky I, Teitelbaum D (1980) Association of autoimmune diseases and cellular immune response to the neuritogenic protein in Guillain-Barré syndrome. Ann Neurol 8: 117

    Google Scholar 

  • Adams D, Gibson JD, Thomas PK et al. (1977) HLA antigens in Guillain-Barré syndrome. Lancet 11: 504–505

    Google Scholar 

  • Ala FA, Shearman DSC (1965) A case of autoimmune hemolytic anaemia, thrombocytopenia, and the Guillain-Barré syndrome. Acta Haematol (Basel) 34: 319–369

    Google Scholar 

  • Amarenco P, Sauron B, Schuller E, Chain F, Castaigne P (1987) Serum and CSF humoral immunity in Guillain-Barré syndrome: clinical correlations. J Neurol Sci 80: 129–142

    PubMed  CAS  Google Scholar 

  • Arnason BGW, Winkler GF, Hadler NM (1969) Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest 21: 1–10

    PubMed  CAS  Google Scholar 

  • Behan PO, Lamarche JB, Feldman RG, Sheremata WA (1970) Lymphocyte transformation in the Guillain-Barré syndrome Lancet 1: 421

    CAS  Google Scholar 

  • Behan PO, Behan WMH, Feldman RG, Kies MW (1972) Cell mediated hypersensitivity to neural antigens. Occurrence in human patients and non-human primates with neurological diseases. Arch Neurol 27: 145–152

    PubMed  CAS  Google Scholar 

  • Behan PO, Lessels S, Roche M (1976) Optic neuritis in the Landry-Guillain-Barré-Strohl syndrome. J Ophthal 60: 58–59

    CAS  Google Scholar 

  • Behar R, Penny R, Powell HC (1986) Guillain-Barré syndrome associated with Hashimoto’s thyroiditis. J Neurol 233: 233–236

    PubMed  CAS  Google Scholar 

  • Bertinelli A, Giani M, Rossi L et al. (1989) Ex novo cases of acute glomerulonephritis and Guillain-Barré syndrome: a case report. Clin Nephrol 31: 269–273

    Google Scholar 

  • Best PV (1985) Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathol 67: 230–234

    PubMed  CAS  Google Scholar 

  • Birnbaum G (1973) Guillain-Barré syndrome. Increased lymphoproliferative potential. Arch Neurol 28: 215–218

    PubMed  CAS  Google Scholar 

  • Bornstein MB, Appel SH (1961) The application of tissue culture to the study of EAE: I. Patterns of demyelination. J Neuropathol Exp Neurol 20: 141–157

    Google Scholar 

  • Bourouresque G, Delpuech F, Giudicelli R et al. (1981) Polyradiculoneuritis and myasthenia gravis. Nouv Presse Méd 10: 253–254

    Google Scholar 

  • Bradbury K, Aparicio SR, Sumner DW et al. (1985) Comparison of in vitro demyelination and cytotoxicity of humoral factors in MS and other neurological diseases. J Neurol Sci 70: 167–181

    PubMed  CAS  Google Scholar 

  • Bradford JB, Bashford EF, Wilson JA (1918) Acute infective polyneuritis. Q J Med 12: 88–126

    Google Scholar 

  • Brock S, Davidson C (1947) Fatal cryptogenic neuropathy. Arch Neurol Psychiatry 58: 559–569

    Google Scholar 

  • Brown MJ, Rosen JL, Lisak RP (1987) Demyelination in vitro by Guillain-Barré syndrome and other human serum. Muscle Nerve 10: 263–271

    PubMed  CAS  Google Scholar 

  • Caspary EA, Currie S, Walton JN, Field EJ (1971) Lymphocyte sensitisation to nervous tissues and muscle in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 34: 179–181

    PubMed  CAS  Google Scholar 

  • Castaigne P, Berthaux P, Brunet P (1972) Polyradiculonévrites inflammatoires et immunité cellulaire: étude de la réponse immunitaire cellulaire envers des antigènes de nerf périphérique par le test de migration des leucocytes. Nouv Presse Méd 1: 2445–2449

    PubMed  CAS  Google Scholar 

  • Colaco CB, Scadding GK, Newsom Davis J (1984) Anticardiolipin antibodies in neurological diseases. Lancet 1: 164

    PubMed  CAS  Google Scholar 

  • Cook SD, Dowling PC (1981) The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol 9 supp1: 70–79

    PubMed  Google Scholar 

  • Cook SD, Dowling PC, Whitaker JN (1970) Serum immunoglobulins in the Guillain-Barré syndrome. Neurology 20: 403

    PubMed  CAS  Google Scholar 

  • Cook SD, Dowling PC, Murray MR, Whittaker JN (1971) Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 24: 136–144

    PubMed  CAS  Google Scholar 

  • Cornblath DR, Griffin JW, Tennekoon GI (1986) Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies. Ann Neurol 20: 370–372

    PubMed  CAS  Google Scholar 

  • Cornblath DR, Griffin DE, Welch D, Griffin JW, McArthur JC (1990) Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 26: 113–118

    PubMed  CAS  Google Scholar 

  • Corston RN (1980) Temporal arteritis in association with Guillain-Barré syndrome. Br Med J 280: 292–293

    PubMed  CAS  Google Scholar 

  • Corston RN, McGale EHF, Stonier C, Aber GM, Hutchinson EC (1981) Abnormalities of CSF amino acids in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 44: 86–89

    PubMed  CAS  Google Scholar 

  • Cruz M, Ernerudh J, Olsson T, Hoseberg B, Link H (1987) Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls. J Neurol Neurosurg Psychiatry 51: 820–825

    Google Scholar 

  • Currie S, Knowles M (1971) Lymphocyte transformation in the Guillain-Barré syndrome. Brain 94: 109–116

    PubMed  CAS  Google Scholar 

  • Cuttner J, Meyer R (1978) Guillain-Barré syndrome in a patient with Hodgkin’s disease. Mt Sinai J Med (NY) 45: 415–417

    CAS  Google Scholar 

  • Drachman DA, Paterson PY, Berlin B, Rogusa J (1970) Immunosuppression and Guillain-Barré syndrome. Neurology 20: 390

    PubMed  CAS  Google Scholar 

  • Dubois-Dalcq M, Buyse M, Buyse G, Gorce F (1971) The action of Guillain-Barré serum on myelin. A tissue culture and electron microscope analysis. J Neurol Sci 13: 67–83

    PubMed  CAS  Google Scholar 

  • Dummolard A, Sarrouy J, Schonshoe R, Baredoux N (1937) Polyradiculonévrite avec hyperalbuminose du liquide cephalorachidien sans réaction cellulaire et névrite optique-evolution rapide, vers le guérison ( Guillain-Barré ). Rev Oto-Neuro-Ophthalmol (Paris) 15: 26–28

    Google Scholar 

  • Eustis-Turf EP, Benjamins JA, Lefford JL (1986) Characterization of the anti-neural antibodies in the sera of leprosy patients. J Neuroimmunol 10: 313–330

    PubMed  CAS  Google Scholar 

  • Feasby TE, Hahn AF, Gilbert JJ (1982) Passive transfer studies in Guillain-Barré polyneuropathy. Neurology 32: 1159–1167

    PubMed  CAS  Google Scholar 

  • Forrester C, Lascelles RG (1979) Association between polyneuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry 42: 864–866

    PubMed  CAS  Google Scholar 

  • Frampton G, Winer JB, Cameron JS, Hughes RAC (1988) Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 19: 133–139

    PubMed  CAS  Google Scholar 

  • Froelich CJ, Searles RP, Davis LE, Goodwin JS (1980) A case of Guillain Barré syndrome with immunologic abnormalities. Ann Int Med 93: 563–565

    PubMed  CAS  Google Scholar 

  • Geczy C, Raper R, Roberts IM, Meyer P, Bernard CCA (1985) Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. J Neuroimmunol 9: 179–191

    PubMed  CAS  Google Scholar 

  • Gorodezky C, Varela B, Castro-Escobar LE, Chavez-Negrete A, Escobar-Gutierrez A, Martinez-Mata J (1983) HLA-DR antigens in Mexican patients with Guillain-Barré syndrome. J Neuroimmunol 4: 1–7

    PubMed  CAS  Google Scholar 

  • Goust JM, Chenais F, Carnes JE, Hames CG, Fudenberg HH, Hogan EL (1978) Abnormal T-cell populations and circulating immune complexes in the Guillain-Barré syndrome and MS. Neurology 28: 421–428

    PubMed  CAS  Google Scholar 

  • Grant H, Leopold HN (1954) Guillain-Barré syndrome occurring during cortisone therapy. JAMA 155: 252–253

    CAS  Google Scholar 

  • Gross PT (1980) Acute idiopathic polyneuritis and idiopathic thrombocytopenic purpura. JAMA 243: 256–257

    PubMed  CAS  Google Scholar 

  • Guilbert L, Dighiero G, Avramea S (1984) Naturally occurring antibodies against urine common antigens in neural humans. I. Detection, isolation and characterization. J Immuno 1128: 2779–2787

    Google Scholar 

  • Guillain G, Barré JA, Strohl A (1916) Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide cephalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des reflexes tendineux. Bull Soc Méd Hôp Paris 40: 1462–1470

    Google Scholar 

  • Harris EN, Engelert H, Derve G, Hughes GRV, Gharavi A (1983) Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 11: 1361–1362

    Google Scholar 

  • Harrison BM, Hansen LA, Pollard JD, McLeod JG (1984) Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann Neurol 15: 163–170

    PubMed  CAS  Google Scholar 

  • Hartung H-P, Schwenke C, Bitter-Suermann D, Toyka KV (1987) Guillain-Barré syndrome: activated complement components C3a and C5a in CSF. Neurology 37: 1006–1009

    PubMed  CAS  Google Scholar 

  • Hartung H-P, Hughes RAC, Taylor WA, Heininger K, Reiners K, Toyka KV (1990) T cell activation in the Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 40: 215–219

    PubMed  CAS  Google Scholar 

  • Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanupak P (1987a) Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 316: 369–374

    PubMed  CAS  Google Scholar 

  • Hemachudha T, Phanuphak P, Johnson RT, Griffin DE, Ratanvongsiri J, Siripramsomsup W (1987b) Neurologic complications of semple-type rabies vaccine: clinical and immunologic studies. Neurology 37: 550–556

    PubMed  CAS  Google Scholar 

  • Hemachudha T, Griffin DE, Chen WW, Johnson RT (1988) Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome. Neurology 38: 375–378

    PubMed  CAS  Google Scholar 

  • Hirano A, Cook SD, Whitaker JN, Dowling PC, Murray MR (1971) Fine structural aspects of demyelination in vitro the effects of Guillain-Barré serum. J Neuropathol Exp Neurol 30: 249–265

    PubMed  CAS  Google Scholar 

  • Hughes RAC (1979) Acute inflammatory polyneuropathy. In: Rose FC (ed) Clinical neuroimmunology. Blackwell, Oxford, pp 170–184

    Google Scholar 

  • Hughes RAC, Cameron JS, Hall SM, Heaton J, Payan JA, Teoh R (1982) Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus -nerve biopsy and response to plasma exchange. J Neurol 228: 239–247

    PubMed  CAS  Google Scholar 

  • Hughes RAC, Asian S, Gray IA (1983) Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis ( Guillain-Barré syndrome ). Clin Exp Immunol 51: 448–454

    PubMed  CAS  Google Scholar 

  • Hughes RAC, Gray IA, Gregson NA et al. (1984) Immune responses to myelin antigens in Guillain-Barré syndrome. J Neuroimmunol 6: 303–312

    PubMed  CAS  Google Scholar 

  • Ilyas AA, Willison HS, Quarles RH, Jungalwala KB, Cornblath DR (1988) Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 23: 440–447

    PubMed  CAS  Google Scholar 

  • Julien J, Vital CL, Aupy G, Laugueny A, Darriet D, Brechenmacher C (1980) Guillain-Barré syndrome and Hodgkin’s disease–ultrastructural study of a peripheral nerve. J Neurol Sci 45: 23–27

    PubMed  CAS  Google Scholar 

  • Kaslow RA, Sullivan-Bolyai JZ, Hafkin B et al. (1984) HLA antigens in Guillain-Barré syndrome. Neurology 34: 240–242

    PubMed  CAS  Google Scholar 

  • Kennett RP, Morgan SH, Dudley C, Mackworth-Young C, Hull R, Hughes GR (1986) Acute polyradiculoneuropathy complicating systemic lupus erythematosus. Postgrad Med J 62: 291–294

    PubMed  Google Scholar 

  • Khoury EL, Ritacco V, Cossio PM et al. (1979) Circulating antibodies to peripheral nerve in American trypanosomiasis ( Chagas disease ). Clin Exp Immunol 36: 8–15

    PubMed  CAS  Google Scholar 

  • Klingon GH (1965) The Guillain-Barré syndrome associated with cancer. Cancer 18: 157–163

    PubMed  CAS  Google Scholar 

  • Korn-Lubetzki I, Abramsky O (1986) Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Arch Neurol 43: 604–608

    PubMed  CAS  Google Scholar 

  • Koski CL, Humphrey R, Shin ML (1985) Anti-peripheral myelin antibodies in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibodies by complement component transfer and fixation. Proc Natl Acad Sci USA 82: 905–909

    PubMed  CAS  Google Scholar 

  • Koski CL, Gratz E, Sutherland J, Mayer RF (1986) Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome. Ann Neurol 19: 573–577

    PubMed  CAS  Google Scholar 

  • Koski CL, Sanders ME, Swoveland PT et al. (1987) Activation of terminal components of complement on patients with Guillain-Barré syndrome and other demyelinating neuropathies. J Clin Invest 80: 1492–1497

    PubMed  CAS  Google Scholar 

  • Koski CL, Chou DKH, Jungalwala FB (1989) Anti-peripheral nerve myelin antibodies in Guillain-Barré syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest 84: 280–287

    PubMed  CAS  Google Scholar 

  • Kruger H, Englert D, Pfughaupt KW (1981) Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing. J Neurol 226: 15–24

    PubMed  CAS  Google Scholar 

  • Lassmann H, Budka H, Schnaberth G (1981) Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol 38: 99–102

    PubMed  CAS  Google Scholar 

  • Latov N, Gross RB, Kastelman J et al. (1981) Complement fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology 31: 1530–1534

    PubMed  CAS  Google Scholar 

  • Link H (1975) Demonstration of oligoclonal immunoglobulin in Guillain-Barré syndrome. Acta Neurol Scand 52: 111–120

    PubMed  CAS  Google Scholar 

  • Link H, Wahren B, Norrby E (1979) Pleocytosis and immunoglobulin changes in CSF and herpes virus serology in patients with Guillain-Barré syndrome. J Clin Microbiol 9: 305–316

    PubMed  CAS  Google Scholar 

  • Lisak RP, Zweiman B, Norman M (1975) Antimyelin antibodies in neurologic diseases: immunofluorescent demonstration. Arch Neurol 32: 163–167

    PubMed  CAS  Google Scholar 

  • Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK (1977) Guillain-Barré syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol 1: 72–78

    PubMed  CAS  Google Scholar 

  • Lisak RP, Kuchmy D, Armati-Gulson PJ, Brown MJ, Sumner AJ (1984) Serum mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome. Neurology 34: 1240–1243

    PubMed  CAS  Google Scholar 

  • Lisak RP, Zweiman B, Guerrero F, Moskovitz AR (1985) Circulating T cell subsets in Guillain Barré syndrome. J Neuroimmunol 8: 93–101

    PubMed  CAS  Google Scholar 

  • Livrea P, Zimatore GB, Simone IL et al. (1980) Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy. J Neurol 223: 1–12

    PubMed  CAS  Google Scholar 

  • Low PA, Schmelzer J, Dyck PJ, Kelly JJ (1982) Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiological studies on normal and demyelinated rat nerves. Neurology 32: 720–724

    PubMed  CAS  Google Scholar 

  • Luijten JAFM, De Jong WAC, Demel RA, Heijnen CJ, Ballieux RE (1985) Peripheral nerve P2 basic protein and the Guillain-Barré syndrome. In vitro demonstration of P2-specific antibody secreting cells. J Neurol Sci 66: 209–216

    Google Scholar 

  • MacGregor GA (1965) Familial Guillain-Barré syndrome. Lancet 11: 1296

    Google Scholar 

  • Mactier RA, Khanna R (1987) Guillain-Barré syndrome in kappa light chain myeloma. South Med J 80: 1054–1055

    PubMed  CAS  Google Scholar 

  • Martin JJ (1961) Polyradiculonévrite avec dissociation albuminocytologique (du type Guillain Barré) et atteinte optique (contribution anatomo-clinique). Psychiatry Neurol 142: 265–292

    CAS  Google Scholar 

  • McCombe PA, Clarke P, Frith JA et al. (1985) Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann Neurol 18: 514–516

    PubMed  CAS  Google Scholar 

  • Mead GM, Cowin P, Whitehouse IMA (1980) Antitubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody. Clin Exp Immunol 39: 228–336

    Google Scholar 

  • Melnick SC (1963) Bcases of the Guillain-Barré syndrome; an immunological study. Br Med J 1:368–373

    PubMed  CAS  Google Scholar 

  • Moreila Filho PF, Cini Cinatus D, Freitas MRG, Nascimento JM, Porto FJS, Santos PC (1980) Guillain-Barré syndrome as a manifestation of SLE. Arq Neuropsiquiatr 38: 165–170

    Google Scholar 

  • Mouren P, Vital-Bernard P, Poinso Y et al. (1971) Névrite optique retrobulbaire au cours d’un syndrome de Guillain-Barré. Rev Oto-Neuro-Ophtalmol (Paris) 43: 216–221

    CAS  Google Scholar 

  • Murphy BF, Gonzales MF, Ebeling P, Fairley KF, Kincaid-Smith P (1986) Membranous glomerulonephritis and Landry—Guillain-Barré syndrome. Am J Kidney Dis 8: 267–270

    PubMed  CAS  Google Scholar 

  • Nikoskelainen E, Riekkinen P (1972) Retrobulbar neuritis as an early symptom of Guillain-Barré syndrome: report of a case. Acta Opthalmol (Copenh) 50: 111–115

    CAS  Google Scholar 

  • Nyland H, Aarli JA (1978) Guillain-Barré syndrome; demonstration of antibodies to peripheral nerve tissue. Acta Neurol Scand 58: 35–43

    PubMed  CAS  Google Scholar 

  • Nyland H, Naess A (1978) Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with acute Guillain-Barré syndrome. Eur Neurol 17: 247–252

    PubMed  CAS  Google Scholar 

  • Okuyama H (1975) Mechanism of increase of the cerebrospinal fluid (CSF) protein content in Guillain-Barré syndrome. Clin Neurol (Tokyo) 15: 817–826

    CAS  Google Scholar 

  • Osterman PO, Vedeler CA, Ryberg B, Fagius J, Nyland H (1988) Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange. J Neurol 233: 285–289

    Google Scholar 

  • Palosuo T, Vaarala O, Kinnunen E (1985) Cardiolipin antibodies in Guillain-Barré syndrome. Lancet 11: 839

    Google Scholar 

  • Potz G, Neundorfer B (1975) Polyradiculoneuritis and Hashimoto’s thyroiditis. J Neurol 210: 283–289

    PubMed  CAS  Google Scholar 

  • Pradalier A, Gettler V, Feyeux C, Dry J (1982) Guillain-Barré polyradiculopathy and segmental colitis. Nouv Presse Méd 11: 35–73

    Google Scholar 

  • Rocklin RE, Sheremata WA, Feldman RG, Kies MW, David JR (1971) Cellular response in Guillain-Barré syndrome and multiple sclerosis. N Engl J Med 284: 803–808

    PubMed  CAS  Google Scholar 

  • Rodriguez-Iturbe B, Garcia R, Rubio L, Zabala J, Maros G, Torres R (1973) Acute glomerulonephritis in the Guillain-Barré—Strohl syndrome. Report of 9 cases. Ann Intern Med 78: 391–395

    PubMed  CAS  Google Scholar 

  • Rosenberg RN, Aung MH, Tindall RSA (1975) Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum: IgG and IgM immunoglobulin studies. Neurology 25: 1101–1110

    PubMed  CAS  Google Scholar 

  • Rostami AM, Burns JB, Eccleston PA, Manning MC, Lisak RP, Silberberg DH (1987) Search for antibodies to galactocerebroside in the serum and CSF in human demyelinating disorders. Ann Neurol 22: 381–382

    PubMed  CAS  Google Scholar 

  • Rozen D, VanHaeverbeek M, Stenuit R, Ardichvili D (1980) Polyradiculitis, B. fragilis septicemia, peritonitis in a patient with SLE. Rev Méd Brux 1: 395–398

    PubMed  CAS  Google Scholar 

  • Ryberg B (1984) Extra and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index. Neurology 34: 1378–1381

    PubMed  CAS  Google Scholar 

  • Sabin AB, Aring CD (1941) Visceral lesions in infectious polyneuritis. Am J Pathol 17: 469–481

    PubMed  CAS  Google Scholar 

  • Sadovnick AD, Paty DW, Yannakoulias G (1989) Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med 321: 762–763

    PubMed  CAS  Google Scholar 

  • Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK (1982) in vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol 11: 69–75

    Google Scholar 

  • Sanders EACM, Lee KD (1987) Acute Guillain-Barré syndrome in multiple sclerosis, J Neurol 234: 128

    PubMed  CAS  Google Scholar 

  • Sanders EACM, Yewdall VMA, Hughes RAC, Cameron JS (1988) Absence of complement activation in demyelinating polyradiculoneuropathies. Ann Neurol 23: 102–103

    PubMed  CAS  Google Scholar 

  • Sanders ME, Koski CL, Robbins D (1986) Activated terminal complement in CSF in Guillain-Barré syndrome and multiple sclerosis. J Immunol 136: 4456–4459

    PubMed  CAS  Google Scholar 

  • Saunders M, Rake M (1965) Familial Guillain-Barré syndrome. Lancet 11: 1106–1107

    Google Scholar 

  • Seares RP, Davis LE, Hermanson S (1981) Lymphocytotoxic antibodies in Guillain-Barré syndrome. Lancet 1: 273

    Google Scholar 

  • Segurado OG, Kruger H, Mertens HG (1986) Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. J Neurol 233: 202–208

    PubMed  CAS  Google Scholar 

  • Seil Fir (1977) Tissue culture studies of demyelinating disease: a critical review. Ann Neurol 2: 345–355

    Google Scholar 

  • Sheremata WA, Colby S, Karkhanis Y, Eylar E (1975) Cellular hypersensitivity to basic myelin ( P2) protein in the Guillain-Barré syndrome. Can J Neurol Sci 2: 87–90

    PubMed  CAS  Google Scholar 

  • Siddiqui B, Haromori S-I (1971) A revised structure for the Forssman glycolipid hapten. J Biol Chem 246: 5766

    PubMed  CAS  Google Scholar 

  • Smith KJ Hall SM (1988) Peripheral demyelination and remyelination initiated by the calciumselective ionophore ionomycin: in vivo observations. J Neurol Sci 83: 37–53

    PubMed  CAS  Google Scholar 

  • Spaar FW, Orthner H (1968) Adrenalitis inclusio necroticans in the Landry-Guillain-Barré syndrome. Dtsch Z Nervenheilkd 193: 195–213

    PubMed  CAS  Google Scholar 

  • Stefansson K, Marton LS, Dieperink ME, Molinar GK, Schlaepfer WW, Helgason CM (1985) Circulating autoantibodies to the 200 000 dalton protein of neurofilaments in the serum of healthy individuals. Science 228: 1117–1119

    PubMed  CAS  Google Scholar 

  • Steiner I, Wirguin I, Abramsky O (1986) Appearance of Guillain-Barré syndrome in patients during corticosteroid treatment. J Neurol 233: 221–223

    PubMed  CAS  Google Scholar 

  • Stewart GJ, Pollard JD, McLeod JG, Wolnizer CM (1978) HLA antigens in the Landry—GuillainBarré syndrome and chronic relapsing polyneuritis. Ann Neurol 4: 285–289

    PubMed  CAS  Google Scholar 

  • Sumner AJ, Saida K, Saida T, Silberberg DH, Asbury AK (1982) Acute conduction block associated with experimental antiserum mediated demyelination of peripheral nerve. Ann Neurol 11: 469–477

    PubMed  CAS  Google Scholar 

  • Tachovsky T, Lisak RP, Koprowski H (1976) Circulating immune complexes in multiple sclerosis and other neurological disorders. Lancet 11: 997–999

    Google Scholar 

  • Taylor WA, Hughes RAC (1989) T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 24: 33–39

    PubMed  CAS  Google Scholar 

  • Toh BH, Yildiz A, Sotelo J, Holborow EJ, Kanankoundi F (1979) Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol 37: 76–82

    PubMed  CAS  Google Scholar 

  • Tonnessen TI, Nyland H, Aarli JA (1982) Complement factors and acute phase reactants in the Guillain-Barré syndrome. Eur Neurol 21: 125–128

    Google Scholar 

  • Tse KS, Arbesman CE, Tomasi TB, Tourville D (1971) Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. Clin Exp Immunol 8: 881–887

    PubMed  CAS  Google Scholar 

  • Uncini A, Treviso M, Basciani M, Onofrj M, Gambi D (1988) Associated central and peripheral demyelination: an electrophysiological study. J Neurol 235: 238–240

    PubMed  CAS  Google Scholar 

  • van Doom PA, Brand A, Vermeulen M (1987) Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 37: 1798–1802

    Google Scholar 

  • Vedeler CA, Nyland H, Matre R (1982) Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by mixed haemagglutination technique. J Neuroimmunol 2: 209–214

    PubMed  CAS  Google Scholar 

  • Wiederholt HM, Mulder DW, Lambert EH (1964) The Landry Guillain-Barré-Strohl syndrome of polyradiculoneuropathy — historical review: report on 97 patients and present concepts. Mayo Clin Proc 49: 427–451

    Google Scholar 

  • Winer JB, Gray IA, Gregson NA et al. (1988a) A prospective study of acute idiopathic neuropathy. III. Immunologic studies. J Neurol Neurosurg Psychiatry 51: 619–625

    PubMed  CAS  Google Scholar 

  • Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RFP (1988b) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51: 613–618

    PubMed  CAS  Google Scholar 

  • Winer JB, Briggs D, Welsh K, Hughes RAC (1988c) HLA antigens in the Guillain-Barré syndrome. J Neuroimmunol 18: 13–16

    PubMed  CAS  Google Scholar 

  • Winer JB, Hughes RAC, Osmond C (1988d) A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 51: 605–612

    Google Scholar 

  • Winkler GF (1965) In vitro demyelination of peripheral nerve induced with sensitized cells. Ann NY Acad Sci 122: 287–296

    PubMed  CAS  Google Scholar 

  • Yonezawa T, Ishihara Y, Matsuyama H (1968) Studies on experimental allergic neuritis. I. Demyelinating patterns studied in vitro. J Neuropathol Exp Neurol 27: 453–463

    Google Scholar 

  • Yonezawa T, Ishihara Y, Sato Y (1969) Demyelinating antibodies of EAE and peripheral neuritis represented by demyelinating pattern in vitro. J Neuropathol Exp Neurol 28: 180–181

    Google Scholar 

  • Yonezawa T, Robbins N, Ishipara Y, Iwanami H, Nakatani Y (1970) In vitro demyelination produced by sera from Landry—Guillain-Barré syndrome. Proc Int Congr Neurol 6: 688–689

    Google Scholar 

  • Zweiman B, Rostami A, Lisak RP, Moskovitz AR, Pleasure DE (1983) Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology 33: 234–237

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hughes, R.A.C. (1990). Immunology of Guillain-Barré Syndrome. In: Guillain-Barré Syndrome. Clinical Medicine and the Nervous System. Springer, London. https://doi.org/10.1007/978-1-4471-3175-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3175-5_9

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3177-9

  • Online ISBN: 978-1-4471-3175-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics